In this episode of Updates in Anesthesiology, Dr. Hadzic explores groundbreaking findings from Chotinaruemol and colleagues, published in the British Journal of Anaesthesia (2025), revealing how dexmedetomidine may do more than sedate. It could protect the kidneys from ischemia-reperfusion injury. From cellular survival pathways to improved surgical outcomes, we break down how DEX works, when it works best, and what this could mean for high-risk surgical patients. Stay tuned for actionable insights you can take straight to the OR.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

Dexmedetomidine: The Kidney's Secret Ally in Surgery?

Anesthesia Updates

Dexmedetomidine: The Kidney's Secret Ally in Surgery?